STOCK TITAN

ARK reports 9.59% stake in Pacific Biosciences (PACB)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 29,781,416 shares of Pacific Biosciences of California, Inc. common stock, representing 9.59% of the class. ARK has sole voting power over 27,781,961 shares and sole dispositive power over 29,781,416 shares, while Catherine D. Wood reports shared voting and dispositive power over these holdings.

Positive

  • None.

Negative

  • None.
Beneficial ownership 29,781,416 shares Total PACB common shares beneficially owned by ARK and Catherine D. Wood
Percent of class owned 9.59% Portion of Pacific Biosciences common stock class beneficially owned
ARK sole voting power 27,781,961 shares Shares for which ARK has sole power to vote or direct the vote
ARK shared voting power 327,377 shares Shares for which ARK has shared power to vote or direct the vote
ARK sole dispositive power 29,781,416 shares Shares for which ARK has sole power to dispose or direct disposition
Catherine Wood shared voting power 28,109,338 shares Shares for which Catherine D. Wood has shared power to vote
Catherine Wood shared dispositive power 29,781,416 shares Shares for which Catherine D. Wood has shared power to dispose
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: ARK and Catherine D. Wood"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power financial
"Number of shares as to which the person has | (i) Sole power to vote"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
shared voting power financial
"(ii) Shared power to vote or to direct the vote"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
sole dispositive power financial
"(iii) Sole power to dispose or to direct the disposition of"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
shared dispositive power financial
"(iv) Shared power to dispose or to direct the disposition of"

FAQ

What percentage of PACB does ARK Investment Management currently own?

ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 9.59% of Pacific Biosciences (PACB) common stock, representing 29,781,416 shares as disclosed in this Schedule 13G/A amendment.

How many PACB shares are beneficially owned by ARK and Catherine Wood?

ARK Investment Management LLC and Catherine D. Wood beneficially own 29,781,416 shares of Pacific Biosciences (PACB) common stock, corresponding to 9.59% of the class, according to the ownership details provided.

What voting power does ARK have over PACB shares?

ARK has sole voting power over 27,781,961 shares of Pacific Biosciences (PACB) and shared voting power over 327,377 shares, reflecting how ARK can direct the vote on most of the reported holdings.

What voting and dispositive power does Catherine D. Wood report over PACB?

Catherine D. Wood reports shared voting power over 28,109,338 shares and shared dispositive power over 29,781,416 shares of Pacific Biosciences (PACB), aligned with ARK’s managed holdings.

Who are the reporting persons on this PACB Schedule 13G/A filing?

The reporting persons are ARK Investment Management LLC and Catherine D. Wood, each reporting beneficial ownership of 29,781,416 PACB shares, or 9.59% of the common stock, with differing sole and shared powers.

What type of security in PACB is reported as owned by ARK and Catherine Wood?

The reported security is common stock of Pacific Biosciences of California, Inc. (PACB), identified by CUSIP 69404D108, with 29,781,416 shares beneficially owned by ARK and Catherine D. Wood.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





69404D108

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



ARK Investment Management LLC
Signature:/s/ Kellen Carter
Name/Title:Kellen Carter, Chief Compliance Officer
Date:08/14/2026
Catherine D. Wood
Signature:/s/ Catherine D. Wood
Name/Title:Catherine D. Wood, Chief Executive Officer, Chief Investment Officer
Date:08/14/2026